INTRODUCTION
Rhodnius prolixus is an important blood-feeding model organism that is extensively used for physiological and endocrinological research. In addition, R. prolixus, commonly known as the kissing bug, is a vector of Chagas disease, and is therefore of some medical importance (Rassi et al., 2010) . Rhodnius prolixus presents some experimental advantages related to its blood-feeding habit. Thus, each unfed instar of R. prolixus essentially remains in a state of arrested development until it takes a blood meal. Blood feeding initiates endocrinological and physiological changes that lead to a timed, and predictable, growth and development to the next instar or adult. A number of neurohormones (peptides and amines) are involved in these transitions, some of which are involved in feeding and digestion, while others are involved in growth and development (see Orchard, 2009; Nässel and Winther, 2010) Recently, Ons and colleagues isolated a number of neuropeptides from the adult R. prolixus brain using an off-line nano-LC-MALDI-MS/MS workflow (Ons et al., 2009) , and subsequently isolated partial cDNAs for these peptides . The neuropeptides included FMRF-like peptides (FLPs) that are found extensively throughout the metazoans (see Walker et al., 2009 ) and share a C-terminal RFamide. Although once referred to as FMRFamide-related peptides, they are now considered to be evolutionarily unrelated (see Orchard and Lange, 2013) . One of these groups of FLPs includes the so-called 'myosuppressins' that are only found in insects and crustaceans. In insects, myosuppressins are found in neurons of the central nervous system (CNS) and in midgut endocrine cells, and are therefore brain/gut peptides. Insect myosuppressins have the general conserved sequence: X 1 DVX 4 HX 6 FLRFamide where X 1 can be pQ, P, T or A; X 4 can be D, G or V; and X 6 can be V, S or I (Orchard et al., 2001; Orchard and Lange, 2013; Nygaard et al., 2011) . The myosuppressin sequence in R. prolixus (Rhopr-MS) isolated by Ons and colleagues (Ons et al. 2009; Ons et al., 2011) has two unique features; the sequence pQDIDHVFMRFamide contains isoleucine (I) in the third position as opposed to the usual valine (V) found in other insects, and also a unique FMRFamide C-terminus and not the usual FLRFamide.
Myosuppressins serve important behavioural and physiological functions in insects (Orchard et al., 2001; Orchard and Lange, 2013) and appear to be one of the core sets of neuropeptides found in all sequenced genomes (see Hauser et al., 2010; Nygaard et al., 2011) . For example, they have been shown to inhibit spontaneous contractions of the heart in Calliphora vomitora (Duve et al., 1993) and Protophormia terraenovae (Angioy et al., 2007) , the midgut and oviducts in Locusta migratoria (Lange and Orchard, 1998; Lange et al., 1991) , and the hindgut in Leucophaea maderae (Holman et al., 1986) . Myosuppressins also inhibit food intake in Blattella germanica (Aguilar et al., 2004 ), they possess anti-feeding properties in Spodoptera littoralis (Vilaplana et al., 2008) and feeding state alters the content of FLPs in endocrine-like cells in the midgut of L. migratoria (Lange, 2001) .
In light of the unique structural features of Rhopr-MS, we sequenced its cDNA, examined its expression in tissues using reverse transcriptase (RT)-PCR, and also tested its ability to be a myosuppressin on a variety of peripheral tissues.
MATERIALS AND METHODS Animals
Fifth instar R. prolixus Stål 1859 were used from a long-standing colony kept at 25°C and 60% humidity at University of Toronto Mississauga. All insects used were unfed, 4-6 weeks postemergence, and were previously fed on defibrinated rabbit blood as 4th instars.
Isolation of Rhopr-MS cDNA by screening the 5th instar CNS cDNA library
The cDNA encoding the Rhopr-MS prepropeptide was isolated by screening the 5th instar R. prolixus cDNA CNS library (see Paluzzi et al., 2008) . The Rhopr-MS amino acid sequence submitted by Ons et al. (Ons et al., 2009 ) (GenBank ID: ACT98134) was used in a TBLASTN search against the R. prolixus preliminary genome assembly database using Geneious Software (Drummond et al., 2010) . The predicted Rhopr-MS-encoding nucleotide sequence obtained was used to design reverse and forward gene-specific primers (GSPs). Modified 5Ј and 3Ј RACE (rapid amplification of cDNA ends) were performed using GSPs and CNS cDNA library vector-specific primers (VSPs) (Table1). The modified RACE procedure allows for amplification of 5Ј and 3Ј ends of cDNA inserts. For example, the 5Ј end was amplified using Myo Rev-1 (GSP) and pDNR-LIB For-2 (VSP) primers and the 3Ј end was amplified using Myo For-1 (GSP) and pDNR-LIB Rev-25 (VSP) primers. After the first round of cDNA amplification, all the products were column purified using a PCR Purification Kit (Bio Basic Inc., Markham, ON, Canada). The purified products were then used as templates for the second (nested) PCR. The PCR conditions for the two rounds of PCR were identical, i.e. 5min initial denaturation at 94°C, 35 cycles of denaturation at 94°C for 15s each, 35 cycles of annealing at 58°C for 30s each, 35 cycles of extension at 72°C for 60s each, and a final extension for 10min at 72°C. PCR products were separated on a 1% agarose gel stained with ethidium bromide. The amplified products of the three PCR reactions were extracted from the gel and column purified using a Gel Extraction Kit (Bio Basic Inc.). The gel-extracted products were then ligated using the pGEM TEasy vector system (Promega, Madison, WI, USA). The vectors were subsequently transformed into E. coli competent cells using Qiagen PCR Cloning plus Kit (Qiagen, Mississauga, ON, Canada). Positive clones containing the desired inserts were purified, and the Rhopr-MS nucleotide sequence determined by the Centre for Applied Genomics at the Hospital for Sick Children (MaRS Centre, Toronto, ON, Canada). The nucleotide sequencing results for the 5Ј end, 3Ј end, and internal region were aligned using Geneious Pro 5.0.4 software (Drummond et al., 2010) .
Sequence analysis of the Rhopr-MS prepropeptide
The presence/location of the signal peptide cleavage sites in the Rhopr-MS prepropeptide sequence was predicted using SignalP 3.0 (Bendtsen et al., 2004) . The nucleotide sequence of Rhopr-MS obtained by screening the CNS cDNA library was used in a BLAST search against the R. prolixus preliminary genome assembly database using Geneious Pro 5.0.4 software (Drummond et al., 2010) , which predicted the location and size of the introns in Rhopr-MS. (Dircksen et al., 2011) ] were aligned using Clustal W (Larkin et al., 2007) . The aligned prepropeptide sequences of identical and similar consensus sequences were denoted with black and grey, respectively, by using the BOXSHADE3.21 server (www.ch.embnet.org/software/BOX_form.html). A phylogenetic tree was created using the protein alignment on Molecular Evolutionary Genetics Analysis (MEGA) Version 4.0.2 software (see Tamura et al., 2007) by using the maximum-likelihood method (see Jones et al., 1992) and is presented along with bootstrap values based on 1000 replicates.
Rhopr-MS expression using RT-PCR
To determine the expression of Rhopr-MS in different tissues of 5th instar R. prolixus, RT-PCR was performed on the CNS, foregut, anterior midgut, posterior midgut, hindgut, Malpighian tubules, testes, ovaries, dorsal vessel/fat bodies/trachea and salivary glands. The tissues were dissected from 5th instar R. prolixus in nucleasefree phosphate-buffered saline (PBS) (Sigma-Aldrich, Oakville, ON, Canada) and were stored in RNAlater TM RNA stabilization reagent (Qiagen Inc.) at -20°C. Total RNA was extracted from each of the tissues using SV Total RNA Isolation System (Promega) and quantified using a NanoDrop 2000 UV spectrophotometer (ThermoFisher Scientific, Wilmington, DE, USA). Total RNA (100ng) was used from each tissue to synthesize cDNA using iScript TM Select cDNA Synthesis Kit (Bio-Rad, Mississauga, ON, Canada), which was used as template to perform PCR. The primers used were Myo For-1 and Myo Rev-1 (Table1), and the conditions of the thermocycler used to run the PCR were the same as described above for modified RACE experiments. To test the quality of the cDNA template, actin was used as a positive control. The RT-PCR products were separated on a 1% agarose gel stained with ethidium bromide.
Immunohistochemistry and bioassays Chemicals
Rhopr-MS (purity 93.1%) was purchased from GenScript USA Inc.
(Piscataway, NJ, USA). Stock solutions in 10l aliquots of 10 -3 moll -1 Rhopr-MS were made using 10% dimethylsulphoxide (DMSO; Sigma-Aldrich) in ddH 2 O, and were stored at -20°C. Further dilutions were made using physiological saline (150mmoll (Lane et al., 1975) . The maximum concentration of DMSO used in the assays was 0.001% and control experiments using this concentration showed no effect on the tested tissues. CaCl 2 ; pH7) was applied for 1h at room temperature. Tissues were then washed with PBS (containing 0.9% NaCl, pH7.2) for 1h with rinses every 5min. The digestive tract and CNS were removed and incubated for 1h at room temperature in 4% Triton X-100 made up in PBS containing 10% normal goat serum (NGS) and 2% bovine serum albumin (BSA). Tissues were then washed with PBS for 1h with rinses every 10min and were subsequently incubated on a shaker for 48h at 4°C in 1:1000 rabbit antiFMRFamide antiserum (INCSTAR, Stillwater, MN, USA) made up in PBS containing 0.4% Triton X-100, 2% BSA and 2% NGS. Following incubations, the tissues were washed in PBS for 2h with rinses every 10min, and then incubated for 18h at 4°C in secondary antibody solution of purified goat anti-rabbit conjugated to Cy3 (diluted 1:600), containing 10% NGS in PBS. Tissues were then washed with PBS for 8h with rinses every 10min. Tissues were mounted on microscope slides in 100% glycerol. FMRFamide-like immunoreactivity was observed with a Zeiss confocal laser microscope (Carl Zeiss, Jena, Germany) and Zen 2009 viewing software (Zeiss). Controls were run whereby the primary antiserum was preabsorbed with 10 -5 moll -1 synthetic Rhopr-MS prior to use. All staining of cell bodies and processes was eliminated using preabsorbed antiserum
Midgut and hindgut assays
Contraction assays were performed on isolated tissues from 5th instar R. prolixus. A fine silk thread was tied at the anterior end of the anterior midgut, and another at the most posterior end of the anterior midgut. The most posterior end was tied to a minuten pin secured to a well in a Sylgard-coated Petri dish containing 200l saline, and the silk thread attached to the anterior end was attached to a force transducer (Aksjeselskapet Mikro-elektronikk, Horten, Norway). For hindgut assays, the posterior end of the hindgut was dissected and kept attached to a small piece of cuticle surrounding the anus. The cuticle and attached hindgut was then secured to a Sylgard-coated Petri dish (in a well containing 200l saline), while the anterior end of the hindgut was tied with a fine silk thread and attached to a force transducer. Anterior midgut and hindgut muscle contractions were monitored on a linear flatbed chart recorder through an amplifier. Rhopr-MS was bath applied to the tissues by removing half of the saline present in the well containing the tissue, and simultaneously replacing it with an equal volume of the test solution at twice the desired, final, concentration.
Heart rate assays
The ventral abdominal cuticle and visceral tissues were removed from 5th instar R. prolixus, leaving the dorsal vessel exposed. Semiintact preparations of the abdominal region of the dorsal vessel and surrounding dorsal cuticle were secured in a dish. Heart rate was measured in saline and in various doses of Rhopr-MS using electrodes connected to an impedance converter (UFI model 2991, Morro Bay, CA, USA). Electrodes were placed on either side of the heart between the sixth and seventh abdominal segments. Preparations were maintained with 50l saline, and test solutions were added by removing all saline, and subsequently adding 50l of the desired concentration of peptide.
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RESULTS
Isolation of the Rhopr-MS cDNA
The modified RACE experiments resulted in cloning of a 437bp long Rhopr-MS cDNA sequence that encodes a prepropeptide of 88 amino acid residues (Fig.1) . Comparison of the nucleotide sequence of Rhopr-MS cDNA with the genomic sequence reveals the presence of two introns and three exons in Rhopr-MS. The first intron is located between nucleotides 120 and 121 (Fig.1 ) and is at least 132,502bp in length. The second intron is located between nucleotides 295 and 296 (Fig.1 ) and is 1479bp in length.
The putative signal peptide sequence is observed within Rhopr-MS prepropeptide and its cleavage site is predicted to be between amino acid residues 16 and 17 using the neural networks (NN) and hidden Markov model (HMM) prediction available on SignalP 3.0 (see Bendsten et al., 2004) (Fig.1) . The mature Rhopr-MS peptide, QDIDHVFMRFG, is released after cleaving at dibasic (KR) and tribasic (RRR) cleavage sites (Fig.1) . The mature Rhopr-MS is amidated and the N-terminal glutamic acid residue forms a pyroglutamic acid during post-translational modification, resulting in the sequence pQDIDHVFMRFamide, as determined by Ons et al. . We have also confirmed the amino acid sequence using matrix-assisted laser desorption/ionization time-offlight mass spectrometry (MALDI-TOF MS) of CNS extracts from 5th instar R. prolixus. A stop codon (TAA) was observed immediately after the tribasic cleavage site. One putative poly-A tail signal was observed at the very 3Ј end of the sequence.
A B
CCA GAT TGT TCT CCA TCT GCA CTA CAA GTA CAA TCC TCT AGA GTG AGA AAC ATG TGT 234
CAG ACT GCT CTC CGA GAC ACG AAC ATA CCG TAT AAC ATA CCT GAG AAG AGA CAA GAT 348
ATT GAC CAC GTA TTC ATG CGC TTT GGA CGT CGA CGT TAA AATACAAGA AAATTTAAGTGGC 410
Intron1 ( 2091 An unusual myosuppressin in R. prolixus
Protein alignment and phylogenetic analysis
Protein alignment was performed using ClustalW Version 2.0 (see Larkin et al., 2007) with myosuppressin prepropeptide sequences (either cloned or predicted from the genome) of 14 different insects, and three species of crustaceans. The protein alignment reveals a highly conserved sequence of the mature myosuppressin in all species of insects and crustaceans included in the alignment (Fig.2A) . However, the crustaceans, P. clarkii and H. americanus, have a leucine (L) residue in the third amino acid position, whereas D. pulex and almost all the other insects examined have a V residue. Interestingly, R. prolixus and A. pisum (both hemipterans) have an I and L residue, respectively, in the third amino acid position (Fig.2A) . Moreover, R. prolixus is the only species among insects and crustaceans known to have a unique FMRFamide C-terminus (Fig.2A) . All other species have an FLRFamide C-terminus (Fig.2A ).
The phylogenetic tree shows that R. prolixus is separated from the hemipteran A. pisum with respect to the myosuppressin prepropeptide, and appears to group with Crustacea. Also, A. pisum and the Diptera, A. aegypti, A. gambia and D. melanogaster, form a monophyletic group (Fig.2B) .
Analysis of Rhopr-MS expression through RT-PCR
Total RNA was extracted from different tissues and used to synthesize cDNA. RT-PCR was performed using cDNA from different tissues as the template. The results show that Rhopr-MS is expressed in only two of the tissues examined, the CNS and posterior midgut of R. prolixus (Fig. 3) . Actin was used as a control to test the quality of the cDNA.
Immunohistochemistry
FMRFamide-like immunoreactivity is distributed extensively in the neurons of the CNS, in processes associated with the hindgut of R. prolixus, and in processes over the foregut and hindgut (Tsang and Orchard, 1991) . Closer examination of the anterior and posterior midgut of 5th instar R. prolixus for FMRFamide-like immunoreactivity revealed FMRFamide-like immunoreactive endocrine-like cells (Fig.4 ). These endocrine-like cells had apical processes that extended towards the midgut lumen.
R.prolixus ----------------MILAWMCVTLLAG------VLAAPGPDCSPSALQVQSSRVRNMC 38
A.pisum ------MSTYRTMLTSVLVLLVVASVCDCR------INNLPTRCMPGLLEDAPPKVREAC 48 B.germanica ----------MKYVSVVLISVLAVLLACMP---HMASAVPPPQCSPNILDDVPPRVRKVC 47 D.punctata ----------MKHLCIVLIGVLTVLLACAP---RRAAAVPPPQCSSNMLEDISPRFRKIC 47 A.echinatior ----------MSSTIMILVSVTTMAILSG----EALAGSPGISCNPGFLDELPPRLRKIC 46 C.floridanus ---------MMSPTLMILISITTMAILSG----ESFGAMP-AQCNSEFLEELPPRLRKIC 46 A.mellifera --MFYLFTSMMGSTIVILFSMTTMTIFCN----NVLAALP-TQCNPGFLDDLPPRIRKVC 53 A.aegypti ---MLRTESMSILFCAVLILNITLITCQA-------TTAVPPICENELIEEMPHRIRKVC 50 A.gambiae --SSQQIASLKAVTCVVLLL-VIVCSLVA-------GSAMPPLCENRLIDELPPKFRKVC 50 D.melanogaster ----MSFAQFFVACCLAIVL-LAVSNTRA-------AVQGPPLCQSGIVEEMPPHIRKVC 48 M.unipuncta ------MALGGNGNHVAVVCLVLACASVA-------LCAPAQLCAGAADDD--PRAARFC 45 S.littoralis ---------------------LHLCAGAA-------LCAPAQLCGGAADDD--PRAARFC 30 B.mori -----MSCFIGEHFRLALVCVVLSWCASA-------WAAPAQLCAAAAEND--PRATRFC 46 T.castaneum --------MQQYAFVAIVFGAVAVFLANAS------TTAYYVSCPPNDALEASTSLRHLC 46 P.clarkii MMCSSSSSSWCSLLLVGVVVALGVCVGVG-------EAIPPPIC-LNQQLPLSPYAKKLC 52 H.americanus MVFR--SCSWSCLLVVGVVVVMGVCVGVG-------ETMPPPIC-LSQQVPLSPFAKKLC 50 D.pulex MPATRGNHHTAATMAVAAVLTFVVLVVVGAPSFAEAGSIPPPHCNPDVSDALPPRLRRIC 60 R.prolixus ALY----QISSALQAYLDEQNNYQTALRDTNIPY-----NIPEKRQDIDHVFMRFGRRR--88 A.pisum LTLSTIRTLSNAIETFIQDKQFPMPMPYSRMSDGLVDTAMQNDKRQDLDHVFLRFGRRRR-108 B.germanica AALSTIYELSNAMEAYLDDKV-----VRENTPLV-----DTGVKRQDVDHVFLRFGRRR--96 D.punctata AALSSIYDLSSAMEAYLEDKV-----VRENTPLM-----DNGVKRQDVDHVFLRFGRRR--96 A.echinatior MAFARIWDVR-DMNDFIDDKE-----YRENLPRY-----DSAVKRQDVDHIFLRFGKRR--94 C.floridanus VAIARIWDAR-EMNDFVDDRE-----YRENLPRY-----DSSVKRQDVDHVFLRFGKRR--94 A.mellifera VALSRIYELGSEMESYIGDKENHITGFHESIPLL-----DSGVKRQDVDHVFLRFGRRR--107 A.aegypti AALENSNQFAEALNAYIRKEAAALLYQGEDLLAP-----SSNGKRTDVDHVFLRFGRKR--104 A.gambiae AALENSNQFAEALNAYIRKEAAAFLYLDDDMLVP-----GQTGKRTDVDHVFLRFGRRR--104 D.melanogaster QALENSDQLTSALKSYINNEASALVANSDDLLK-------NYNKRTDVDHVFLRFGKRR--100 M.unipuncta QALNTFLELYAEAAGEQVPEYQALVRDYPQLLD-------TGMKRQDVVHSFLRFGRRR--97 S.littoralis QALNTFLELYAEAAGEQVPEYQALVRDYPQLLD-------TGMKRQDVVHSFLRFGRRR--82 B.mori QALNTFIELYAEAAGEQVPEYQALIRDYPQLLD-------TGMKRQDVVHSFLRFGRRR--98 T.castaneum SFIEQAVNDNVVIQDEPFRRI-----VGRNVNPN--------TKRQDVDHVFLRFGRPFGL 94 P.clarkii AALSNISEFSRAMEEYLD--AQ-AVKN--LMPVN-----EPEVKRQDLDHVFLRFGRSQ--101 H.americanus SALINISEFSRAMEEYLG--AQ-AIER--SMPVN-----EPEVKRQDLDHVFLRFGRSQQ-100 D.pulex AALYGIAEISNAVEQYLDDKSN-ATMRDPSMTDS-----DRGVKRQDVDHVFLRFGRR---
Physiological effects of Rhopr-MS on peripheral tissues
Rhopr-MS decreased the frequency and amplitude of spontaneous phasic contractions of the anterior midgut (Fig.5 ) and hindgut ( Rhopr-MS for the hindgut, and resulted in a cessation of contractions. Rhopr-MS also decreased heart rate ( Fig.7) , with the
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, and total inhibition of heartbeat occurred at 10 -7 moll -1 . The EC 50 for inhibition of contraction for hindgut was 1.3ϫ10 -9 moll -1 and for heart it was 6ϫ10 -9 moll -1 .
DISCUSSION
Since the discovery of the molluscan cardioacceleratory tetrapeptide FMRFamide (Price and Greenberg, 1977) , a variety of neuropeptides that share the C-terminal RFamide have been characterized in insects. These FLPs fall into several families of peptides, one of which is the myosuppressins (see Orchard and Lange, 2013; Nässel and Winther, 2010 FLRFamide (where X 1 is pQ, Q, P, T or A; X 4 is D, G or V; and X 6 is V, S or I). We have partially cloned the myosuppressin cDNA in R. prolixus, resulting in a 437bp nucleotide sequence that codes for an 88 amino acid prepropeptide. The amino acid sequence of the open reading Table1) primers were used to amplify the Rhopr-MS cDNA sequence in different tissues and the expected product size was 410bp. The primers used for positive control (actin) are expected to give a product of 320bp. Two negative controls were performed, one in which cDNA was synthesized without adding any RNA, and a second that contained no cDNA template. The numbers indicate the following tissues: (1) CNS, (2) testes, (3) ovaries, (4) foregut, (5) anterior midgut, (6) posterior midgut, (7) hindgut, (8) dorsal vessel/fat bodies/trachea, (9) Malpighian tubules, (10) salivary glands, (11) no template, (12) negative control. Tissues from at least 10 insects were dissected and pooled. The results shown are of three independent biological replicates. frame is identical to that identified previously Sterkel et al., 2011) . After post-translational modifications, a mature decapeptide is produced, which has the sequence: pQDIDHVFMRFamide. The myosuppressin in R. prolixus has some unique features wherein X 3 is I and X 8 is M (methionine). Interestingly, other extended FMRFamides are also found in R. prolixus , resulting in the only FMRFamide to be found outside of the dipterans and the only myosuppressin without an FLRFamide motif. The myosuppressin cDNA was recently cloned in another hemipteran, the pea aphid, A. pisum, and it contains L in the third amino acid position (Shigenobu et al., 2010) . The R. prolixus myosuppressin is also unique from other insect myosuppresins in that the amino acid in position three is I whereas V is conserved in most insects. Interestingly, in H. americanus and P. clarkii, the third position is occupied by the amino acid L similar to that seen in A. pisum.
Ons et al. , using bioinformatic tools and manual analysis, predicted that there are four peptides encoded in the myosuppresin prepropeptide with three of these confirmed by MALDI-TOF MS/MS; QDIDHVFMRFamide, pQDIDHVFMRFamide and pQDIDHVF(M-OH)RFamide. The latter two myosuppressins were confirmed using nano-LC and ESIOrbi-Trap MS/MS and are post-translationally modified versions of QDIDHVFMRFamide. The presence of pQ (pyro-glutamate) is common in myosuppressins of insects (see Nässel and Winther, 2010; Orchard and Lange, 2013) , but the addition of a hydroxide group on the methionine has not been reported for myosuppresins and could either be a rare form of this peptide or a result of the procedure used to isolate these peptides during mass spectrometry (Ons et al., 2010) . We have also confirmed the presence of pQDIDHVFMRFamide by MALDI-TOF MS from CNS extracts of R. prolixus. More experiments must be performed to confirm the existence and quantity of the various myosuppressins and their presence in a variety of tissues in R. prolixus. RhoprMS (mol l -1 ) Heart rate (% of control) Fig.7 . The effect of Rhopr-MS on the heart rate of 5th instar R. prolixus. (A)Sample traces illustrate that Rhopr-MS inhibits the frequency of heart contractions. (B)Dose-response curve shows that increasing the concentration of Rhopr-MS leads to a dose-dependent decrease in heart rate relative to saline controls. Data are means ± s.e.m., N6.
The RT-PCR results show that Rhopr-MS mRNA is expressed in the CNS and posterior midgut. The Rhopr-MS cDNA was isolated and sequenced using the CNS cDNA library, which also indicates its presence in the CNS. Recently, Rhopr-MS expression was also observed in the posterior midgut of R. prolixus but not in the crop (anterior midgut) or hindgut . In situ hybridization in M. sexta and D. punctata reveals myosuppressin expression in endocrine cells of the posterior midgut (Fusé et al., 1998; Lu et al., 2002) .
Immunohistochemistry using an anti-RFamide antibody in R. prolixus reveals immunostained processes projecting to the hindgut (Tsang and Orchard, 1991) and also positively stained endocrinelike cells throughout the entire midgut (this study). These endocrinelike cells appear to be of the open type with processes extending from the cell body towards the lumen. The presence of myosuppressin in endocrine-like cells of the midgut suggests that myosuppressin plays a role in feeding/digestion. A number of studies have now shown a role of FLPs in feeding-related behaviour. Vilaplana et al. have shown that myosuppressins inhibit food intake in S. littoralis (Vilaplana et al., 2008) . Moreover, in B. germanica, mRNA expression levels of myosuppressin slightly decrease during maximum food intake . Myosuppressins also stimulate the release of the digestive enzyme -amylase in the red palm weevil (beetle), Rynchphorus ferrugineus (Nachman et al., 1997) . Therefore, it appears that myosuppressin may play a role in digestion, acting as a neurotransmitter directly delivered to the hindgut and midgut tissue or locally released from endocrine-like cells. The presence of FLPs in the haemolymph of R. prolixus indicates that it might be acting as a neurohormone . In R. prolixus, myosuppressin expression is not present in the salivary glands; however, FLPs in the nerve supply to the salivary glands indicate that myosuppressin may act as a neurotransmitter at this tissue (Orchard and Te Brugge, 2002) .
Myosuppressins, as their name implies, inhibit contractions of visceral and cardiac muscle (see Orchard et al., 2001; Nässel and Winther, 2010; Orchard and Lange, 2013) , but in some insect species they have also been shown to enhance the force of neurally evoked contractions of skeletal muscle (Robb and Evans, 1994) . Myosuppressins also stimulate enzyme secretion and inhibit shortcircuit current in the midgut, and inhibit the release of adipokinetic hormones (see Orchard et al., 2001; Orchard and Lange, 2013) . Injection of the cockroach myosuppressin into B. germanica inhibits food intake, with food accumulating in the foregut . In R. prolixus, Rhopr-MS was very effective in inhibiting the frequency and amplitude of phasic contractions of the anterior midgut (crop) and hindgut, as well as decreasing heart rate, with an EC 50 of 1.3ϫ10 -9 moll -1 for the hindgut and 6ϫ10 -9 moll -1 for heart rate. In all three tissues, Rhopr-MS was capable of eliminating all phasic contractions.
It is interesting that even though the amino acid sequence of Rhopr-MS has some unique features it still retains inhibitory activity over visceral and cardiac muscle contraction. An in vitro binding assay has been used to characterize the putative receptors for L. migratoria myosuppressin associated with the oviduct and CNS of L. migratoria (Wang et al., 1995a ) (see also Orchard et al., 2001; Orchard and Lange, 2013) , and structure-activity relationships have been examined in L. maderae hindgut and L. migratoria oviduct (see Orchard et al., 2001 ). In the hindgut, VFLRFamide appears to be the active core for inhibitory biological activity. In the oviduct, the amide is crucial for both binding with the receptor and inhibitory biological activity. Interestingly, VFLRFamide, which produces stimulatory responses on the locust oviduct, is the The Journal of Experimental Biology 215 (12) minimum sequence required for receptor binding whereas HVFLRFamide is the minimum sequence for comparable inhibitory biological activity (Wang et al., 1995a) . Therefore, in the locust oviducts, inhibitory and stimulatory peptides share a single receptor but are capable of producing opposite muscle responses, via two different intracellular signalling systems, as a result of differences in the activation sites. Structure/activity experiments examining binding affinity and physiological activity of HVFLRFamide analogues indicate that replacement of the L with a similar amino acid such as V resulted in an analogue that bound to the receptor with reduced potency but was still capable of inhibiting contractions of locust oviducts (Wang et al., 1995b) . Replacement with a dissimilar amino acid such as D (aspartate) resulted in reduced binding and no biological activity. The present data using Rhopr-MS indicate that myosuppressins can also tolerate a change to M in the 8th position and still bind to the receptor and have inhibitory activity.
The isolation and cloning of Rhopr-MS cDNA and the demonstration that the peptide retains myosuppressin activity even though it has a unique amino acid sequence, is of some interest. The myosuppressins are considered to be one of the core neuropeptides, with their genes present in all insect genomes (see Hauser et al., 2010; Nygaard et al., 2011) . As such, they must control fundamental processes required by all insects. The physiological and behavioural role of Rhopr-MS needs to be examined in detail to better understand the significance of this peptide in the medically important bug R. prolixus.
